Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DataMeds AI, Inc. - Common Stock (NQ:MEDS)

3.110 -0.390 (-11.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about DataMeds AI, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
DataMeds AI, Inc. (NASDAQ:MEDS) announced that its Interim Co-CEO Gerald Commissiong will present “What Patients Really Want” at this year’s National Telehealth and Virtual Care Summit in Las Vegas on... 
Via B2i Digital
Topics Artificial Intelligence
News headline image
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
Interim Co-CEO to Discuss Growing Patient Desire to Own Health Data 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMEDS AI Unveils New Corporate Website
DataMEDS AI, Inc. (NASDAQ:MEDS) (the “Company” or “DataMEDS”), a Health IT company vertically integrating health data acquisition and transfer, today announced that it launched its new corporate... 
Via B2i Digital
Topics Artificial Intelligence Retirement
News headline image
DataMeds AI Provides Update on Corexa Health's Pharmacy Division
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMEDS AI Unveils New Corporate Website
Updated Website Aligns with Pending Marketing Initiatives Following Recent Acquisition of Helomics CLIA-certified Laboratory and Litigation Settlement 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
Small-Cap Stocks VEEA, ANY, MEDS, MYSZ Watch Now
Via AB Newswire
Topics Artificial Intelligence
News headline image
DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute
Acquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand Services into Cancer Management 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
Axe Compute Sells Helomics AI Cancer Diagnostics Lab Business to DataMEDS AI, Completing Transition to Neocloud GPU-as-a-Service platform
All-stock sale gives Axe Compute equity stake in DataMEDS AI; aligns APU’s operating structure with its scaling GPU-as-a-Service business 
From Axe Compute Inc
Via GlobeNewswire
News headline image
Datameds, AI., and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National Campaign Rollout
Leading Healthcare IT Company and Former NFL Players Will Work Together to Provide Rural Communities Access to Telehealth and Pharmacy-based Services Through Health Lives Here Mobile App 
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
CORRECTION FROM SOURCE: DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM)
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here"
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid(R) and Galactovid(TM)
From DataMEDS AI, Inc.
Via ACCESS Newswire
InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Expands DataMEDS Licensing Agreement Into Commercial Healthcare
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
News headline image
Datavault AI Expands Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License With DataMeds AI
From Datavault AI Inc.
Via Business Wire
News headline image
DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
From DataMEDS AI, Inc.
Via ACCESS Newswire
News headline image
DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets
From DataMEDS AI, Inc.
Via ACCESS Newswire
TinyGemsBreaks – TRxAde Health Inc. (NASDAQ: MEDS) Changes Name to Scienture Holdings Inc.
Via Investor Brand Network
BioMedNewsBreaks — TRxADE Health Inc.’s (NASDAQ: MEDS) Subsidiary Expands Capabilities with Changes to Executive Leadership Team
Via Investor Brand Network
BioMedNewsBreaks — TRxAde Health Inc. (NASDAQ: MEDS), Scienture Inc. Announce All-Stock Business Combination Resulting in Combined Company
Via Investor Brand Network
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Announces Special Cash Dividend
Via Investor Brand Network
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Regains Compliance with Nasdaq Listing Rule 5250(c)(1), Posts Over $21M in Net Income for Q1 2024
Via Investor Brand Network
Market Momentum: Analyzing Five Stocks Exhibiting Strong Upward Trends: INBS, MEDS, IFBD, AISP, VTAK
Via AB Newswire
InvestorNewsBreaks – TRxADE Health Inc. (NASDAQ: MEDS) Board Declares Special Cash Dividend
Via Investor Brand Network
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.